/

Sociétés

F.

Non vérifié

F. Hoffmann-La Roche Ltd

Ce que nous écrivons

Annonces ÉconomiquesIndustrie pharmaceutiquePublicité/Marketing/Médias/Communication

140 communiqués de presse

Voir tous les communiqués de presse

17/06/2026

Industrie pharmaceutique

Annonces Économiques

FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma

Source

F. Hoffmann-La Roche Ltd

Émetteur

1.00

0

12/06/2026

Industrie pharmaceutique

Annonces Économiques

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

Source

F. Hoffmann-La Roche Ltd

Émetteur

1.00

0

10/06/2026

Industrie pharmaceutique

Annonces Économiques

Publicité/Marketing/Médias/Communication

FDA grants Priority Review for Roche’s Tecentriq for a certain type of stage III colon cancer

Source

F. Hoffmann-La Roche Ltd

Émetteur

1.00

0

07/06/2026

Industrie pharmaceutique

Annonces Économiques

Publicité/Marketing/Médias/Communication

Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology

Source

F. Hoffmann-La Roche Ltd

Émetteur

1.00

0

01/06/2026

Industrie pharmaceutique

Annonces Économiques

Publicité/Marketing/Médias/Communication

FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting

Source

F. Hoffmann-La Roche Ltd

Émetteur

1.00

0

31/05/2026

Industrie pharmaceutique

Annonces Économiques

Publicité/Marketing/Médias/Communication

Roche to present new data advancing its obesity portfolio at the American Diabetes Association’s 2026 Scientific Sessions

Source

F. Hoffmann-La Roche Ltd

Émetteur

1.00

0

26/05/2026

Industrie pharmaceutique

Annonces Économiques

Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease management

Source

F. Hoffmann-La Roche Ltd

Émetteur

1.00

0

18/05/2026

Industrie pharmaceutique

Annonces Économiques

Publicité/Marketing/Médias/Communication

Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancer

Source

F. Hoffmann-La Roche Ltd

Émetteur

1.00

0

11/05/2026

Industrie pharmaceutique

Annonces Économiques

Publicité/Marketing/Médias/Communication

Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)

Source

F. Hoffmann-La Roche Ltd

Émetteur

1.00

0

06/05/2026

Industrie pharmaceutique

Annonces Économiques

Publicité/Marketing/Médias/Communication

Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics

Source

F. Hoffmann-La Roche Ltd

Émetteur

1.00

0

Followers

0

Compatibilité

0